Award recordCONTRACT

ACTELION PHARMACEUTICALS US, INC.

PIID VA26012P0115· VHA· 260-NETWORK CONTRACT OFFICE 20· 6505 · DRUGS AND BIOLOGICALS· FY2012· $178,703 net obligations· UEI H5BMHLMMNA28· CA

Description

BULK FUNDING PURCHASE FOR VENTAVIS INJ. PHARMACY

First action · last action
2012-06-22 · 2013-03-21
Transactions
2
First transaction's obligation
$190,704
Base + all options value (sum of deltas)
$178,703
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5160B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$190,704$0Base award · 2012-06-22 · this action $190,704 · running total $190,704Modification P00001 · 2013-03-21 · this action -$12,001 · running total $178,703
  • Base2012-06-22+$190,704= $190,704
  • Mod P000012013-03-21-$12,001= $178,703
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-06-22+$190,704$190,704BULK FUNDING PURCHASE FOR VENTAVIS INJ. PHARMACY
Mod P00001· CLOSE OUT2013-03-21−$12,001$178,703BULK FUNDING PURCHASE FOR VENTAVIS INJ. PHARMACY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H5BMHLMMNA28)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0477245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,052FY2026
36C24526N0181245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,235FY2026
36C26026F0024260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$65,500FY2026
36C26026F0017260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$406,538FY2026
36C26025F0209260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$197,168FY2025
36C26025F0107260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$70,630FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26016F0697LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20$6,829FY2016
VA26016F0673UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20$8,906FY2016
VA26016J0622SANOFI VACCINES US INC.260-NETWORK CONTRACT OFFICE 20$396,690FY2016
VA26016J0621SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$176,120FY2016
VA26016J0613SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$74,617FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26012P0115_3600_V797P5160B_3600 · retrieved 2026-09-26.